Loading company…
Quarry Thera develops proximity-induced therapeutics using molecular glue technology.
Founded in 2025 by Mikael Dolsten and based in New Haven, US, Quarry Thera is a biotechnology company developing small-molecule therapeutics. It uses molecular glue technology, DNA-encoded libraries, structure-guided drug design and medicinal chemistry to target proteins. In November 2025, it raised USD 32 million in Series A funding from Canaan Partners, F-Prime Capital, Lilly Ventures and Yosemite Management.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in